Stocks · News reference
Prestige Consumer (NYSE:PBH) raises FY2027 Adj EPS guidance from $4.42-$4.51 to $4.55-$4.65 vs $4.53 analyst estimate. Raises FY2027 sales outlook from $1.100 billion-$1.121 billion to $1.290 billion-$1.315 billion vs
Reference details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Filed: 2026-08-14 AccNo: 0001295947-26-000049 Size: 141 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Read original at edgarPrestige Consumer (NYSE:PBH) reported quarterly earnings of $0.98 per share which beat the analyst consensus estimate of $0.88 by 11.36 percent. This is a 3.16 percent increase over earnings of $0.95 per share from the
Read original at benzingaPrestige Consumer Healthcare completed its acquisition of LaCorium Health for approximately $150 million on July 1, 2026. The company also priced a $400 million offering of 6.25% senior notes due 2034, with proceeds intended to redeem $400 million of existing 5.125% senior notes due January 2028. LaCorium, an Australian therapeutic skincare company generating ~$40 million in annual revenue, is expected to contribute approximately $12 million in EBITDA post-integration.
Read original at globenewswire-inc